You are here

Article info

Article menu
Colon
Original research
Novel TCF21high pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix

Authors

  1. Correspondence to Professor Dongmei Zhang, College of Pharmacy, Jinan University, Guangzhou, Guangdong, China; dmzhang701{at}jnu.edu.cn; Professor Wencai Ye, College of Pharmacy, Jinan University, Guangzhou, Guangdong, China; chywc{at}aliyun.com; Dr Minfeng Chen, College of Pharmacy, Jinan University, Guangzhou, Guangdong, China; minfengchen{at}jnu.edu.cn; Professor Yihai Cao, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Stockholm, Sweden; yihai.cao{at}ki.se
View Full Text

Citation

Li X, Pan J, Liu T, et al
Novel TCF21high pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix
Gut 2023;72:710-721.

Publication history

  • Received May 22, 2022
  • Accepted August 20, 2022
  • First published September 7, 2022.
Online issue publication 
March 07, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.